Literature DB >> 15895002

Ethical issues in genetic testing.

Dale Halsey Lea1, Janet Williams, M Patricia Donahue.   

Abstract

Genetic factors contribute to risk for disease. Information clarifying risk in an individual and his/her family members can be identified through clinical screening and genetic testing. In some circumstances, this information can be used in clinical decisions about surveillance and prevention or treatment of disease. However, use of this information is not always a straightforward process. Application of knowledge about risk of genetic disease in provision of primary health care for women requires understanding of new genetic discoveries as well as the ability to participate in resolution of ethical dilemmas that may result when genetic screening and testing are considered. These dilemmas arise not only from the current state of knowledge about genetic risk factors and utility of genetic tests but also result from conflicts that can arise when the needs of the client are not in unison with needs of others within the family or society. Ethical theories and principles provide a framework for resolving ethical dilemmas in maternal screening for genetic conditions during a pregnancy, carrier testing prior to or during a pregnancy, clinical genetic testing, and newborn metabolic screening.

Entities:  

Mesh:

Year:  2005        PMID: 15895002     DOI: 10.1016/j.jmwh.2004.12.016

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  3 in total

Review 1.  The Role of Regulatory Agencies and Intellectual Property: Part I.

Authors:  Kevin E Noonan
Journal:  Cold Spring Harb Perspect Med       Date:  2015-03-16       Impact factor: 6.915

2.  Attitude of Reproductive Healthcare Providers to Prenatal Diagnosis in a Low Resource Nigerian Setting.

Authors:  Leonard Ogbonna Ajah; Silas Alegu Nwali; Christopher Chim Amah; Theophilus Ogochukwu Nwankwo; Lucky Osaheni Lawani; Benjamin Chukwuma Ozumba
Journal:  J Clin Diagn Res       Date:  2017-02-01

Review 3.  Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.

Authors:  David J Tester; Michael J Ackerman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.